# Lecture 10: Newborn and Pediatric Ethics; Parental Authority
## Foundations of Medical Ethics and the Health Humanities
---
## Learning Objectives
By the end of this lecture, students will be able to:
1. Explain the ethical principles governing medical decision-making for children and newborns
2. Distinguish between parental authority, best interest standard, and the harm principle in pediatric ethics
3. Analyze cases involving conflict between parental wishes and medical recommendations
4. Discuss the evolving concept of the child's assent and the mature minor doctrine
5. Examine ethical issues unique to neonatal intensive care and pediatric end-of-life decisions
---
## Lecture Content
### I. The Unique Ethical Landscape of Pediatric Medicine
Pediatric medicine presents a distinctive ethical landscape because children cannot provide informed consent. They lack both the cognitive development and the legal standing required for autonomous decision-making. This creates a triadic relationship among physician, parent or guardian, and child, raising fundamental questions: Who decides for the child? What standards guide those decisions? When can or should the child's own voice be heard? When is it appropriate to override parental decisions?
Pediatric ethics bridges two different ethical orientations. Autonomy-based frameworks, designed for adults, must be adapted for patients who cannot yet exercise autonomy. Protection-based frameworks, designed for those who cannot protect themselves, must be applied without becoming paternalistic or dismissive of the child's developing agency.
### II. Parental Authority and Its Justifications
Parents are the default decision-makers for their children, and this authority is justified on several grounds. Parents possess intimate knowledge of their child's needs, values, and family context. They are generally presumed to want the best for their children. Family integrity has value, and state intervention should be limited. Parents also have constitutionally recognized liberty rights to raise their children according to their values, as affirmed in Wisconsin v. Yoder (1972) and Parham v. J.R. (1979).
However, parental authority is not absolute. It is best understood as a fiduciary responsibility rather than a property right. Parents hold authority in trust for the child's benefit, not as a matter of ownership. When parental decisions cause serious harm or constitute neglect, the state may intervene under the parens patriae doctrine.
### III. Decision-Making Standards for Children
Three standards guide decisions about children's medical care. The best interest standard is the most widely used: the surrogate should choose the option that best promotes the child's well-being, considering medical benefit, quality of life, relief of suffering, and future opportunities. Critics note, however, that this standard is highly subjective and can impose the values of the dominant culture on minority families.
The harm principle, proposed by Douglas Diekema, argues that the best interest standard is too broad and too interventionist. Instead, Diekema proposes that the state should intervene only when parental decisions pose a significant risk of serious harm to the child. This sets a higher threshold for intervention and better respects family diversity.
Lainie Friedman Ross's constrained parental autonomy framework gives parents broad latitude in decision-making, constrained by the child's basic needs. This approach recognizes that "good enough" parenting is the appropriate standard rather than "optimal" parenting, and that parents may make decisions that are not ideal but fall within the range of reasonable.
A diagram showing three concentric zones representing the range of parental decision-making. Innermost zone (green): "Clearly in the child's best interest" -- medical team and parents agree; no ethical conflict. Middle zone (yellow): "Zone of parental discretion" -- reasonable people could disagree; parents have latitude to decide based on family values, religious beliefs, or differing risk assessments. Outermost zone (red): "Harm threshold" -- parental decision poses significant risk of serious harm; state intervention justified. Examples are given for each zone.
### IV. The Child's Voice: Assent and the Mature Minor
Assent is the child's affirmative agreement to participate in treatment or research. It is not legally binding -- consent comes from the parent -- but it is ethically important because it respects the child's developing autonomy. Assent should be sought in a developmentally appropriate manner: a seven-year-old and a fourteen-year-old can participate in decisions at very different levels. The American Academy of Pediatrics recommends that assent be sought when children are capable, typically around age seven or eight for basic assent, with increasing involvement as they mature.
Dissent -- when a child actively objects -- should be taken seriously, especially in older children and adolescents. However, dissent is not always honored. A five-year-old who refuses a vaccination can be overridden with relatively little ethical controversy, while a fifteen-year-old who refuses cancer treatment raises far more complex issues.
The mature minor doctrine recognizes that some minors who demonstrate sufficient maturity and understanding can consent to their own medical care. Gillick competence, established in the UK in 1985, holds that a child under sixteen can consent to treatment if they possess sufficient understanding and intelligence. Factors considered include age, maturity, the complexity and risk of the decision, and the minor's demonstrated understanding.
Adolescent-specific issues include confidentiality protections that allow minors in many jurisdictions to consent to STI treatment, contraception, mental health care, and substance use treatment without parental involvement. The balance between the adolescent's growing autonomy and ongoing parental responsibility requires ongoing negotiation. Gender-affirming care for adolescents represents an increasingly complex ethical and legal terrain with evolving standards.
### V. Neonatal Ethics
Neonatal ethics confronts some of medicine's most difficult decisions, particularly at the threshold of viability. Periviability -- approximately twenty-two to twenty-five weeks gestational age -- is a zone where survival is possible but uncertain and morbidity risk is high. The central question is when it is ethical to initiate or withhold resuscitation. Factors to consider include gestational age, birth weight, presence of anomalies, and parental wishes. No single gestational age serves as a definitive cutoff; decisions should be individualized.
Quality of life considerations are unavoidable in neonatal ethics. Severe prematurity may result in significant disability, including cerebral palsy, intellectual disability, blindness, and chronic lung disease. But who defines an acceptable quality of life? Parents, physicians, and disability advocates may reach very different conclusions. The disability rights critique points out that quality-of-life judgments often reflect bias against disability rather than the lived experience of disabled people.
The ethical equivalence of withholding and withdrawing treatment is firmly established: there is no moral difference between not starting a treatment and stopping one that is not working. In practice, however, withdrawing treatment -- such as removing a ventilator -- feels psychologically harder than withholding it. Palliative care in neonatology, focused on comfort when curative treatment is futile or disproportionately burdensome, is an increasingly recognized option.
Cases involving conjoined twins, severe anomalies, and anencephaly raise questions about survival, quality of life, futility, proportionality, parental wishes, and the suffering of the infant. These cases resist simple resolution and demand careful, multidisciplinary deliberation.
A timeline diagram showing the spectrum of neonatal viability and ethical decision-making. The horizontal axis represents gestational age from 20 to 40 weeks. Marked zones: 20-22 weeks: "Pre-viable -- comfort care recommended." 22-25 weeks: "Periviable zone -- individualized decisions based on clinical factors, parental values, and institutional capabilities; shared decision-making." 25-28 weeks: "Increasing viability -- resuscitation generally recommended, with parental consent." 28+ weeks: "Viable -- standard resuscitation and treatment." Key ethical considerations are noted at each zone.
### VI. Conflicts Between Parents and Medical Teams
Conflicts between parents and medical teams arise in several common scenarios. Parents may refuse recommended treatment based on religious beliefs, as when Jehovah's Witness parents refuse blood transfusion for a child. Parents may demand aggressive treatment when the medical team believes it is futile, such as continuing ICU care for a child with irreversible brain injury. Or parents may choose alternative medicine over standard treatment, such as naturopathy instead of chemotherapy for cancer.
Approaches to conflict resolution should follow a clear sequence. Communication comes first: the clinical team should explore the parents' values, fears, and understanding, ensuring they have been fully informed. Ethics consultation should be sought to involve the hospital ethics committee for guidance and mediation. Negotiation may identify compromise solutions, such as integrating prayer with medical treatment. Legal intervention should be pursued only as a last resort, seeking a court order to override parental decisions when the child faces serious harm or death. Courts have generally ordered treatment when the child's life is at stake but are more reluctant to intervene when the outcome is uncertain or quality of life is debated.
Regarding religious refusal of treatment, most jurisdictions hold that parents do not have a legal right to deny life-saving treatment to their children on religious grounds. As the Supreme Court stated in Prince v. Massachusetts (1944), "Parents may be free to become martyrs themselves. But it does not follow they are free...to make martyrs of their children."
### VII. Ethical Issues in Pediatric Research
Children cannot consent to research, so additional protections are required. Institutional review boards evaluate the risk level of proposed research involving children, classifying it as minimal risk, greater than minimal risk with prospect of direct benefit, or greater than minimal risk without direct benefit. Parental permission plus the child's assent (when developmentally appropriate) are both required.
Historically, children were excluded from research, leading to inadequate pediatric drug dosing and evidence -- a situation that earned children the label "therapeutic orphans." The resulting tension is real: protecting children from research risk is essential, but ensuring they benefit from evidence-based medicine is equally important.
---